To investigate in detail the expression of glycosphingolipids (GSLs) on endothelial cells, 4.85 × 10 9 human umbilical vein endothelial cells (HUVECs) were cultivated in a 2 l bioreactor using microcarriers as a support for anchorage dependent growing cells. Neutral GSLs and gangliosides were isolated and their structures were determined by TLC immunostaining, fast atom bombardment-mass spectrometry (FAB-MS) of the native GSLs, and gas chromatography-electron impact mass spectrometry (GC-EIMS) of partially methylated alditol acetates. GbOse 4 Cer, GbOse 3 Cer, and LacCer, all carrying mainly C24-and C16-fatty acid beside C18-sphingosine, were detected as the major neutral GSLs (36%, 23%, and 15% of the total orcinol stain, respectively); GlcCer, nLcOse 4 Cer, and nLcOse 6 Cer were expressed to substantial minor amounts (9%, 12%, and 5% of the total orcinol stain, respectively). TLC immunostaining revealed the presence of lipid bound Lewis x antigen, whereas the isomeric Lewis a structure was detectable only in very low quantities. G M3 (Neu5Ac) with C18-sphingosine was the major ganglioside constituting about 90% of the whole ganglioside fraction. The fatty acid composition was determined by GC-MS of fatty acid methyl esters, indicating the predominance of C24-and C16-substituted G M3 (Neu5Ac), followed by C18-and C22-substituted species. Terminally α2-3 sialylated neolactoseries ganglioside IV 3 Neu5Ac-nLcOse 4 Cer was the second most abundant ganglioside in HUVECs (8% of the total resorcinol stain), and IV 6 Neu5Ac-nLcOse 4 Cer and VI 3 Neu5Ac-nLcOse 6 Cer (together less than 2% of total resorcinol stain) were found in minor quantities. Lipid bound sialyl Lewis x antigen with poly-N-acetyllactosaminyl chains, and traces of gangliotetraose-type gangliosides G M1 and G D1a were identified by TLC immunostaining. The expression of dominant neutral GSLs LacCer, GbOse 3 Cer, and GbOse 4 Cer, and of ganglioside G M3 (Neu5Ac) was assayed by indirect immunofluorescence microscopy of cell layers grown in chamber slides, each showing different plasma membrane and subcellular distribution patterns. The complete structural characterization of GSLs from HUVECs contributes to our understanding about their functional role, not only of the carbohydrate but also of the lipid moiety, as receptors for bacterial toxins, as cell surface antigens of cellular interaction and as receptors for blood components and macromolecules of the extracellular matrix.
Introduction
Glycosphingolipids (GSLs), composed of a hydrophobic ceramide moiety and a hydrophilic carbohydrate portion, are located primarily in the outer leaflet of the plasma membrane but are also found in association with intracellular organelles (Gillard et al., 1993) . Their structures and functions have been widely reviewed (Hakomori, 1990; Bergelson, 1995) . GSLs act as receptors for toxins, bacteria and viruses (Karlsson, 1995) and provide biological specificity for numerous cellular functions such as cell growth regulation, development, and differentiation (Feizi, 1991; Bremer, 1994; Hakomori and Igarashi, 1995) . GSL oligosaccharide chains spread out in the aqueous environment at the cell surface, and this makes them excellent candidates for cell surface and cell-cell recognition molecules (Schnaar, 1991; Crocker and Feizi, 1996) .
There is abundant evidence that endothelial cells are actively involved in processes that affect human health and disease (Bevilacqua, 1993; Lasky, 1995; McEver, 1997) . The luminal side of blood vessels is covered with a continuous endothelium, and, due to its unique position between the intracellular and extracellular spaces, the active processes of endothelial cells include interaction with neutrophils, platelets, and other inflammatory cells. Although the importance of GSLs as cell surface antigens and receptors has been well documented in recent years, the GSL composition of endothelial cells has generally received less attention than other membrane constituents. Human umbilical vein endothelial cells (HUVECs), like all normal human diploid cells, show a finite life span in vitro and require growth factors for their proliferation and long-term cultivation. Because GSLs are present in cells in small amounts and nontransformed cells grow slowly, it is difficult to obtain sufficient amounts of purified GSLs for their detailed structural characterization. Therefore, information on the GSL composition of human endothelial cells is limited (Gillard et al., 1987) . Mass cultivation of anchorage dependent cells on microcarriers is the only way to get adequate amounts. We reported a large scale cultivation of HUVECs on microcarriers in a specifically designed bioreactor (Duvar et al., 1996) and used the methodology in this study to isolate and structurally characterize GSLs of the in vitro propagated HUVECs. To our knowledge, this is the first report about the full structural characterization of the major GSLs from HUVECs by immunochemical procedures combined with mass spectrometry analysis. 
Results

Bioreactor production of HUVECs
HUVECs (4.85 × 10 9 ) at high viability of 95% were produced by three batch-fermentations with identical and constant culture parameters (microcarrier concentrations, O 2 tension, etc.) (Duvar et al., 1996) , rendering a bulk of homogeneous cells which were used as a source for isolation and structural characterization of GSLs from HUVECs. Subconfluent grown microcarriers showed the spread morphology of HUVECs during exponential growth and confluent covered beads the typical cobblestone pattern with strict contact inhibition, resulting in a regular cell monolayer at confluence (Duvar et al., 1996) .
Neutral GSLs of HUVECs
Total neutral GSLs were 2200 µg, which corresponded to 0.45 µg/10 6 cells. GSL structures were verified by immunostaining with specific anti-neutral GSL antibodies on thin-layer chromatograms. GbOse 4 Cer, GbOse 3 Cer, and LacCer were detected as the main neutral GSLs in HUVECs (36%, 23%, and 15% of the total orcinol stain, respectively); GlcCer, nLcOse 4 Cer, and nLcOse 6 Cer were expressed to substantial minor amounts (9%, 12%, and 5% of the total orcinol stain, respectively). Figure 1 shows the orcinol-stained TLC of whole neutral GSLs (lane a) and as examples the TLC immunostains of whole neutral GSL fraction with anti-GbOse 3 Cer (lane b), anti-GbOse 4 Cer (lane c), anti-nLcOse 4 Cer (lane d), and anti-Forssman GSL antibodies (lane e). As known from former studies, the anti-nLcOse 4 Cer antibody also binds to nLcOse 6 Cer due to the identity in their terminal disaccharides Galβ1-4GlcNAc-R (Figure 1, lane d) . Structures longer than GbOse 4 Cer of the globo-series, like the Forssman GSL, were not detected ( Figure 1 , lane e). Neutral GSLs of the ganglio-series (GgOse 3 Cer and GgOse 4 Cer) were not found. Table I ) were chromatographed in solvent I.
FAB and GC mass spectrometry of major neutral GSLs from HUVECs
Individual neutral GSLs were obtained by reversed phase HPLC, followed by final purification on small silica gel 60 columns. The orcinol-stained TLC of purified single neutral GSLs is shown in Figure 2 . Neutral GSLs were analyzed as native samples in negative ion FAB-MS to get data on the composition and sequence of sugar chains and the type of the ceramide moiety. Beside glucosyl-and lactosylceramide (compounds 1, 2, and 3 in Table I ), neutral GSLs of the globo-series were identified according to their typical hexosyl sequence ions as well-separated triaosyl-and tetraosylceramides with long (C24:0) and short (C16:0) fatty acid chains, respectively (compounds 4-7 in Table I ). As an example, the FAB mass spectrum of native GbOse 3 Cer ( Figure 2 , lane f; compound 5 in Table I ) is shown in Figure 3 . The FAB-MS data and the structures of main neutral GSLs of HUVECs are summarized in Table I .
The structures of HUVEC neutral GSLs were further verified by GC-EIMS of partially methylated alditol acetates. The results from methylation analysis were in agreement with the glycosidic structures expected for neutral globo-series GSLs. While the neutral GSLs in fraction 1 yielded only one derivative isographic with 1,5-di-O-acetyl glucitol (terminal unsubstituted glucose in monohexosylceramide), the compounds contained in fractions 2-7 gave rise to the formation of 1,4,5-tri-O-acetyl glucitol, the expected derivative of the 4-O-substituted core sugar of mammalian GSLs. Methylation analysis of fractions 2 and 3 yielded unsubstituted galactose (1,5-di-O-acetyl derivative) in addition to 4-O-substituted glucose and thus contained lactosylceramide. Fractions 4-7 revealed the presence of a 4-O-substituted galactose (1,4,5-tri-O-acetyl derivative), inferring the occurrence of globo-type trisaccharides in these compounds. In fractions 4 and 5 the 4-O-substituted galactose was only accompanied by a terminal galactose (1,5-di-O-actyl derivative) and should be derived from the unsubstituted globotrihexosyl moiety of GbOse 3 Cer. A further extension of this trisaccharide unit was indicated in fractions 6 and 7 by formation of the 1,5-di-O-acetyl N-acetylgalactosaminitol in conjunction with 1,3,5-tri-O-acetyl galactitol which are the expected derivatives of GbOse 4 Cer. Table I ) from HUVECs obtained by negative ion FAB-MS.
TLC immunodetection of minor neutral GSLs in HUVECs
Positive CD15 bands obtained with anti-Galβ1-4(Fuc-α1-3)GlcNAcβ1-R antibody below nLcOse 6 Cer, revealed the presence of lipid bound Lewis x antigen with poly-N-acetyllactosaminyl chains (extended fucosylated neolacto-series GSLs) in HUVECs. The Lewis x positive GSLs were expressed in relatively smaller amounts in HUVECs compared to human granulocytes (data not shown). TLC immunostaining with the C0514 monoclonal antibody revealed the isomeric Lewis a antigen only in small (less than Lewis x ) quantities in HUVECs (data not shown).
Gangliosides of HUVECs
Total gangliosides (ganglioside fraction I) were 8100 µg, corresponding to 1.67 µg/10 6 cells. The major ganglioside (∼90%) within the whole ganglioside fraction was G M3 (Neu5Ac), followed by terminally α2-3 sialylated neolactoseries ganglioside IV 3 Neu5Ac-nLcOse 4 Cer (8% of the total resorcinol stain). IV 6 Neu5Ac-nLcOse 4 Cer and VI 3 Neu5Ac-nLcOse 6 Cer (making together less than 2% of the total resorcinol stain) were found in minor quantities. Predominant G M3 (Neu5Ac) was verified with the polyclonal chicken anti-G M3 (NeuAc) antibody by TLC immunodetection (not shown). The TLC overlay assay with the chicken anti-G M3 (Neu5Gc) antibody was negative, indicating the absence of Neu5Gc-substituted G M3 , as well as the search for prolonged structures of G M3 (Neu5Ac), i.e., G D3 and G M2 , which were not expressed by HUVECs (data not shown).
FAB and GC mass spectrometry of G M3 (Neu5Ac) specimens
The resorcinol-stained TLC of the G M3 (Neu5Ac) specimens obtained by reversed phase HPLC of ganglioside fraction II is shown in Figure 4 . Native gangliosides were submitted to negative ion FAB-MS to define their structural parameters, such as sugar size and sequence, attachment site of Neu5Ac, and the ceramide involved. The G M3 species present in HUVECs, separated by TLC (see Figure 4) , differed in the fatty acid of their ceramide moiety. The complete list of molecular and sequence fragment ions is given in Table II . The clear-cut data of the 24:0 species (compound 1 in Table II; Table II and Figure 4 , lanes d, e, and f, respectively). Table II) were chromatographed in solvent II. The asterisk indicates a resorcinol-negative compound. For fatty acid analysis, G M3 (Neu5Ac) specimens were hydrolyzed, the resultant fatty acid methyl esters extracted with n-hexane, and analyzed without further purification by GC-MS. Fatty acid methyl esters were identified after electron-impact ionization according to their molecular and characteristic fragment ions. The fatty acid distribution for G M3 (Neu5Ac) fractions 1-5 is summarized in Table III. GC-mass spectrometry of partially methylated alditol acetates of all 5 G M3 (Neu5Ac) specimens revealed the presence of methylated 1,3,5-tri-O-acetyl galactitol and 1,4,5-tri-O-acetyl glucitol, in accordance with the glycosidic structure of G M3 . No hexosamine derivative (trace at m/z = 159) or alternatively substituted hexose (trace at m/z = 118) was detectable with the exception of trace amounts of 1,5-di-O-acetyl galactitol which may be derived from partial desialylation of the ganglioside.
Detection of neolacto-series gangliosides
The procedure for selective detection of terminally α2-3 and α2-6 sialylated neolacto-series gangliosides involves TLC immunostaining of separated gangliosides with an antinLcOse 4 Cer antibody with or without V.cholerae neuraminidase preincubation. G M3 (Neu5Ac) and neolacto-series gangliosides from human granulocytes, consisting of IV 3 Neu5Ac-nLcOse 4 Cer, IV 6 Neu5Ac-nLcOse 4 Cer, and VI 3 Neu5Ac-nLcOse 6 Cer, have been used as references. As shown in Figure 5A (lane a), each ganglioside migrates as a double band due to substitution with C24 fatty acid (upper band) and C16 fatty acid (lower band). After incubation of human granulocyte gangliosides with V.cholerae neuraminidase on a TLC plate, IV 3 Neu5Ac-nLcOse 4 Cer and VI 3 Neu5Ac-nLcOse 6 Cer, as well as IV 6 Neu5Ac-nLcOse 4 Cer, were visualized with the antinLcOse 4 Cer (anti-Galβ1-4GlcNAc-R) antibody ( Figure 5C , lane a). Without neuraminidase treatment two positive IV 6 Neu5Ac-nLcOse 4 Cer bands ( Figure 5B , lane a) were detected since sialylation at position 6 of the terminal galactose does not hinder recognition (Müthing and Neumann, 1993) . The presence of lactosamine containing gangliosides in HUVECs was proven by this method. The two faint resorcinol positive bands below G M3 (Neu5Ac) ( Figure 5A , lane b) were identified as ganglioside IV 3 Neu5Ac-nLcOse 4 Cer (8% of the total resorcinol stain) as shown in Figure 5C (lane b). This structure was confirmed by FAB-MS and GC-MS outlined in the next paragraph. Double bands chromatographing at the position of reference IV 6 Neu5Ac-nLcOse 4 Cer and VI 3 Neu5Ac-nLcOse 6 Cer ( Figure 5C , lane a), were detected in the HUVEC fraction ( Figure 5C , lane b; less than 2% of the total resorcinol stain).
FAB and GC mass spectrometry of IV 3 Neu5Ac-nLcOse 4 Cer
Two IV 3 Neu5Ac-nLcOse 4 Cer specimens were isolated by gradient Iatrobeads chromatography (=ganglioside fraction III). The resorcinol-stained chromatogram indicated one major upper and one minor lower band on the level of reference IV 3 Neu5Ac-nLcOse 4 Cer from human granulocytes (data not shown). Basic data for structural analysis of IV 3 Neu5Ac-nLcOse 4 O-acetyl N-acetyl glucosaminitol, 1,4,5-tri-O-acetyl galactitol, and 1,4,5-tri-O-acetyl glucitol. The composition and pattern of monosaccharide substitution were in agreement with that of IV 3 Neu5Ac-nLcOse 4 Cer (sialylparagloboside). However, the fraction contained a contaminating compound (∼30%) corresponding to a substitution isomer; this was indicated by the formation of 1,3,4,5-tetra-O-acetyl galactitol but absence of 1,5-di-O-acetyl galactitol.
TLC immunodetection of minor gangliosides in HUVECs
Positive CD15s (sialyl Lewis x ) bands obtained by TLC overlay with anti-Galβ1-4(Fucα1-3)GlcNAcβ1-R antibody after neuraminidase treatment indicated the presence of lipid bound sialyl Lewis x antigen with poly-N-acetyllactosaminyl chains whereas the isomeric sialyl Lewis a structure was undetectable. However, it should be mentioned that TLC overlay assays with the monoclonal anti-sialyl Lewis x antibodies, CSLEX1 and AM-3, were negative. TLC immunostaining also could not detect VIM-2 antigens (CDw65) and sulfoglucuronyl-neolacto series structures with HNK-1 epitope in the ganglioside fraction of endothelial cells (data not shown).
Detection of gangliosides with G M1 -core
G M1 can be visualized on a TLC plate with choleragenoid, and G D1a , G D1b , G T1b , and G Q1b by conversion with V.cholerae neuraminidase to G M1 prior to treatment with choleragenoid according to Wu and Ledeen (1988) . G M1 and G D1a were detected in trace quantities in HUVECs, not detectable by resorcinol staining.
Immunohistochemistry
Immunohistochemistry should be an adequate method for determining not only the presence of membrane components but also their localization in the cellular structures. The expression of dominant neutral GSLs and of ganglioside G M3 (Neu5Ac) was proved by indirect immunofluorescence microscopy using carbohydrate-specific chicken polyclonal antibodies. Subconfluent grown cell layers cultivated in chamber slides showed different GSL specific plasma membrane and subcellular distribution patterns. A series of immunofluorescence micrographs revealing the distribution of the neutral GSLs LacCer, GbOse 3 Cer, and GbOse 4 Cer (according to the biosynthesis pathway) was performed in parallel with DAPI staining of nuclear DNA in the same fields. The color reaction obtained with the anti-LacCer antibody revealed a weak plasma membrane staining, but a strong intracellular stain of LacCer positive structures around the nucleus. As an example of the series of immunofluorescence micrographs, the anti-GbOse 3 Cer stained HUVECs are shown in Figure 7A in parallel with the corresponding DAPI staining of nuclear DNA in the same field ( Figure 7B ). The anti-GbOse 3 Cer antibody showed increased plasma membrane staining and a network-like distribution in the cytoplasm in the vicinity of the nucleus. The anti-GbOse 4 Cer antibody indicated homogeneous plasma membrane distribution of GbOse 4 Cer and a strong subcellular expression. Positive staining was also obtained with the anti-nLcOse 4 Cer and the anti-Lewis x (CD15) antibodies. A control staining with an anti-GgOse 4 Cer antibody was negative. Ganglioside G M3 (Neu5Ac) was found to be predominantly expressed on the cell surface, showing only moderate fluorescence around the nucleus. Parallel cultures stained with the secondary DTAF-labeled antibodies only were negative in all cases. To confirm the lipid nature of positive stainings by anti-GSL antibodies, control cultures were treated with methanol and chloroform/methanol (1:1, by vol.) before immunostaining. Considerable reduction of immunofluorescence intensity was always obtained but various amount of remaining fluorescence indicated in some cases cross-reactivity with protein-bound oligosaccharides.
Discussion
As environmental factors in cell cultures (pH value, hypoxia, and shear stress) alter the physiology of endothelial cells (Worthen et al., 1987; Farber and Rounds, 1990; Michiels et al., 1994) we paid particular attention to the scale-up cultivation of adherently growing endothelial cells, using a membrane stirred and bubblefree aerated 2 l bioreactor system (Duvar et al., 1996) . This system accomplished the technical demands of controlled culture conditions and low stress in swirled culture flasks. This bioreactor equipment was also successfully used for large scale production and GSL characterization of bovine aortic endothelial cells (Müthing et al., 1996b; Duvar et al., 1997) . In both cases we used serum from the same species: calf serum for bovine and human serum for HUVECs, reflecting to the in vivo environment of both cell types. Therefore, the GSL expression for example of HUVECs (Gillard et al., 1987) or of porcine aorta endothelial cells (Bouhours et al., 1996) , cultivated in fetal calf serum supplemented medium (xenogenic for both species) and under hardly reproducible conditions in culture flasks, does not permit a detailed comparison with regard to the quantities particularly of minor GSLs due to the different culture conditions. However, we will discuss and refer to the differences of major GSL series of endothelial cells from different species and tissues, which might not be altered by using various culture conditions, in the following paragraph.
The GSL composition of endothelial cells vary greatly between different species and within the same species in regard to their origin from different vascular beds. Primary porcine endothelial cells were found to express GbOse 4 Cer and GbOse 3 Cer as the major neutral GSLs (like HUVECs) and Galα1-3Gal-and Fucα1-2Gal-terminated penta-and heptaglycosylceramides of the neolacto-series (Bouhours et al., 1996) . The predominance of neolacto-series and the lack of globo-series neutral GSLs is characteristic for bovine aortic endothelial cells (Duvar et al., 1997) , whereas HUVECs are enabled to synthesize both series as shown by us and others (Gillard et al., 1987) . Bovine brain and aortic endothelial cells express almost the same major neutral and acidic GSLs (Kanda et al., 1994) . However, the most prominent difference between these two cell types was the biosynthesis of sulfoglucuronyl nLcOse 4 Cer in brain, which was undetectable in aortic endothelial cells using the monoclonal antibody HNK-1. The presence of this sulfate and glucuronic acid-carrying GSL was also reported in rat brain microvessels (Miyatani et al., 1990) . We did not find it in HUVECs, indicating its specific expression in brain vascular cells of different species. The overall feature of all endothelial cells analyzed so far is the dominance of G M3 . However, G M3 -expression also indicates the strongest difference between the species because cells of porcine (Bouhours et al., 1996) and bovine origin (Kanda et al., 1994; Duvar et al., 1997) synthesize G M3 (Neu5Gc), whereas the N-glycolylated variant of G M3 is not synthesized by human cells. The same difference was found for the substitution of neolactotype gangliosides with Neu5Gc in bovine and Neu5Ac in human endothelial cells (Duvar et al., 1997) .
GSLs with Le x and sialyl Lewis x determinants were recognized by TLC immunostaining in the neutral and acidic GSL fraction, respectively, of unstimulated HUVECs. However, sialyl Lewis x was not detectable with the monoclonal antibody CSLEX1, but with an anti-Lewis x monoclonal antibody after neuraminidase treatment. These results are in agreement with reports from Renkonen and co-workers showing the expression of sialyl Lewis x epitope on HUVECs and on lymph node high endothelial venules, where it facilitates the L-selectin-dependent lymphocyte homing to lymph nodes (Majuri et al., 1994; Renkonen et al., 1997, and references therein) .
Globotriaosylceramide and galabiosylceramide having a terminal Galα1-4Gal disaccharide sequence are the specific receptors for verotoxins 1 and 2 (Lingwood et al., 1987; Waddell et al., 1990 ; and references therein). Both toxins have been found to be associated with hemorrhagic colitis and hemolytic uremic syndrome, pathologies of the endothelial cells lining the capillaries of the gastrointestinal tract and the renal glomerulus, respectively. Lingwood and coworkers have demonstrated the important role of GbOse 3 Cer fatty acid microheterogeneity responsible for different verotoxins binding capacities. This was shown by use of the TLC overlay and microtiter plate binding assay (Pellizzari et al., 1992) as well as in cell reconstitution experiments in vitro (Kiarash et al., 1994) indicating that the binding of verotoxin to GbOse 3 Cer in a lipid matrix is affected by the ceramide fatty acid chain length of the GSL. C20:0 and C22:1 fatty acid containing GbOse 3 Cer had the greatest capacity to bind verotoxin 1, whereas C18:0 and C18:1 homologues showed the greatest capacity for verotoxin 2c binding. In all cases an unsaturated fatty acid in GbOse 3 Cer increased verotoxin binding (Kiarash et al., 1994) . Our study showed that GbOse 3 Cer with C24:0 and C16:0 fatty acid were the dominant GbOse 3 Cer species in HUVECs. This could at least in part explain the lower accessibility of verotoxins towards GbOse 3 Cer in HUVECs compared to renal endothelial cells. Also the latter cells have 50 times larger GbOse 3 Cer content compared to HUVECs (Obrig et al., 1993) .
Regarding the presumed functional aspects of endothelial GSLs, several GSLs have been reported to be involved in biomolecular interaction via "head-to-head" contact by interaction of their oligosaccharides belonging to different cells (for reviews, see Hakomori 1990; Hakomori and Igarashi, 1995; and references therein) . GSLs with Lewis x motifs, G M3 and lactosylceramide of HUVECs are potential candidates for heterotypic cell aggregation of leukocytes and endothelial cells (Eggens et al., 1989; Kojima et al., 1991 Kojima et al., , 1992 . The specific modulation of cell surface GSLs by inflammatory mediators such as interferon-γ, tumor necrosis factor-α, and interleukin-1 suggests that GSLs may play a role in the altered adhesive and receptor activities of activated endothelial cells (Gillard et al., 1990; van de Kar et al., 1992) . Using in vitro cultivated cells like HUVECs or other endothelial cells in order to elucidate the functional role of GSLs in cell-cell or cell-toxin interactions, full characterization of GSL structures, such as reported in this study for in vitro grown HUVECs, is a necessary prerequisite. Referring to the early report published two decades ago by Huang (1978) , the functional role of GSLs in cell-cell adhesion events still remains to be clarified and is of outstanding importance for further investigations.
Materials and methods
Cells and culture conditions
Primary HUVECs were isolated according to the procedure described by Gimbrone et al. (1974) and the modifications of Friedl et al. (1989) . HUVECs were cultivated in gelatin precoated polystyrene culture flasks (Duvar et al., 1996) in a 1:1 mixture of Iscove's MDM and Ham's F12 basal medium (Gibco BRL, Eggenstein, Germany) supplemented with 20% (v/v) human serum (German Red Cross Blood Transfusion Service, Institute Springe, Germany), 2.1 g NaHCO 3 , 1.25 µg/l human basic fibroblast growth factor (bFGF, Sigma GmbH, Deisenhofen, Germany), 5 mg/l sodium heparin (Serva Chemie, Heidelberg, Germany), 2 mmol/l glutamine, 12.5 µmol/l β-mercaptoethanol, 5 mg/l iron saturated human transferrin (Behring Werke AG, Marburg, Germany), 65 mg/l benzylpenicillin, and 100 mg/l streptomycin sulfate (=culture medium). A cell bank of HUVECs was established with cells of the third passage, which were used for large scale production on microcarriers in bioreactors (see next paragraph).
Mass cell cultivation
Anchorage dependent HUVECs were propagated on gelatin precoated Dormacell microcarriers (Pfeifer & Langen, Dormagen, Germany) as recently reported in detail (Duvar et al., 1996) . Briefly, inoculums for 2 l bioreactor cultivations, corresponding to the seventh passage, were prepared in 200 ml spinner cultures containing 3 g/l of Dormacell microcarriers (type 2.9% nitrogen content). Scale-up batch fermentations were performed in a 2 l membrane stirred bioreactor as outlined elsewhere (Duvar et al., 1996) . The microcarriers covered with HUVECs were washed twice with phosphate-buffered saline (PBS) before chloroform/ methanol extraction (see below).
Isolation of GSLs from HUVECs
GSLs from 4.85 × 10 9 cells corresponding to a volume of about 330 ml packed beads covered with HUVECs, which were obtained from 3 consecutive batch fermentations, were isolated according to standard procedures (Ledeen and Yu, 1982) as described in detail by Duvar et al. (1997) . Neutral GSLs and gangliosides were separated by anion exchange chromatography on DEAE-Sepharose CL-6B (Pharmacia Fine Chemicals, Freiburg, Germany) as reported by Müthing et al. (1987) . The ganglioside fraction was incubated for 1 h at 37_C in aqueous 1 N NaOH to saponify phospholipids followed by neutralization with acetic acid and dialysis. Neutral GSLs and gangliosides were further purified by adsorption chromatography on silica gel 60 (Merck) and Iatrobeads 6RS-8060 (Macherey-Nagel, Düren, Germany), respectively, as described by Ueno et al. (1978) . Finally, neutral GSLs were purified by Florisil (Merck) chromatography as their peracetylated derivatives (Saito and Hakomori, 1971) .
Purification of neutral GSLs
Individual neutral GSLs were obtained by reversed phase HPLC. The HPLC system used (Gilson Abimed, Langenberg, Germany) consisted of three M303 HPLC pumps, a high pressure mixer M811 and a fraction collector M202. The whole fraction of neutral GSLs was dispersed in 1 ml of methanol/water (90/10, v/v), applied to a reversed phase column (Nucleosil 7RP 18 250 mm × 4 mm, Macherey-Nagel) and eluted with an one step gradient from methanol/water (90/10, v/v) to methanol/water (100/0, v/v). Final purification of single neutral GSLs was performed on a small silica gel 60 column by stepwise elution from chloroform/methanol (7/1) to (2/1), each by volume.
Ganglioside fractionation
The whole ganglioside fraction eluted from Iatrobeads with chloroform/methanol (1/2, by vol.) was designated as ganglioside fraction I. G M3 (Neu5Ac) and IV 3 Neu5Ac-nLcOse 4 Cer were isolated by successive chloroform/methanol elution with 85/15, 75/25, 65/35, 60/40, 55/45, 1/3 (each by volume) , and methanol. Elution with chloroform/methanol (65/35, v/v) gave ganglioside fraction II (G M3 (Neu5Ac)) and the pooled (60/40, v/v) and (55/45, v/v) eluates represented ganglioside fraction III (IV 3 Neu5Ac-nLcOse 4 Cer). Individual G M3 (Neu5Ac)-specimens were obtained by reversed phase HPLC as described above for the purification of individual single GSLs.
High performance thin-layer chromatography
GSLs were separated on high-performance thin-layer chromatography plates (HPTLC-plates, size 10 cm × 10 cm, thickness 0.2 mm, Merck; Art. no. 5633). Neutral GSLs were chromatographed in solvent I (chloroform/methanol/water, 120/70/17, each by vol.) and gangliosides in solvent II (chloroform/methanol/water, 120/85/20, each by vol.), the latter supplemented with 2 mM CaCl 2 . Neutral GSLs were visualized with orcinol (Svennerholm, 1956 ) and gangliosides with resorcinol (Svennerholm, 1957) . Chromatograms were scanned with a CD60 scanner (Desaga, Heidelberg, Germany) equipped with an IBM compatible personal computer and densitometric software. Bands were measured in reflectance mode at 580 nm (resorcinol) and 550 nm (orcinol) with a light beam slit of 0.1 × 2 mm.
Reference GSLs
A reference neutral GSL fraction with LacCer and nLcOse 4 Cer as main components was prepared from human granulocytes (see Müthing et al., 1994a) . A ganglioside mixture composed of G M3 (Neu5Ac), IV 3 Neu5Ac-nLcOse 4 Cer (sialylparagloboside), IV 6 Neu5Ac-nLcOse 4 Cer and VI 3 Neu5Ac-nLcOse 6 Cer was isolated from human granulocytes as previously described .
Monoclonal and polyclonal antibodies; cholera toxin B subunit
Neutral GSL specific monoclonal and polyclonal antibodies and their respective dilutions employed for TLC immunostaining have been recently reported (Duvar et al., 1997) . The polyclonal rabbit anti-GgOse 4 Cer and chicken anti-LacCer, antiGbOse 3 Cer, anti-GbOse 4 Cer, and anti-nLcOse 4 Cer antibodies have also been characterized in earlier publications (Bethke et al., 1986; Müthing and Mühlradt, 1988; Müthing and Neumann, 1993; Müthing et al., 1994a; Müthing and Kemminer, 1996; Müthing and Cacic, 1997) . The specificity of the monoclonal anti-Forssman GSL antibody has been previously reported (Bethke et al., 1986 (Bethke et al., , 1987 . The monoclonal anti-Lewis x , anti-GgOse 3 Cer, and anti-Lewis a antibodies were the same as in our recent study (Duvar et al., 1997) .
Ganglioside-specific monoclonal and polyclonal antibodies and their respective dilutions employed for TLC immunostaining have been recently reported (Duvar et al., 1997) . The polyclonal chicken anti-G M3 (Neu5Ac), anti-G M3 (Neu5Gc), and antinLcOse 4 Cer (the latter used for the detection of neolacto-series gangliosides after neuraminidase treatment) have been characterized in our former reports (Müthing and Neumann, 1993; Müthing et al., 1994a,b; Müthing and Kemminer, 1996) . The anti-sialyl Lewis x antigen antibody producing hybridoma (clone CSLEX1, HB 8580) was from the American Type Culture Collection (ATCC; Rockville, MD). The anti-sialyl Lewis x (AM-3), the VIM-2 specific CDw65 and the anti-HNK-1 monoclonal antibody, the latter specific for sulfoglucuronyl-neolacto series GSLs, were the same as in our previous studies (Müthing et al., 1996a; Duvar et al., 1997) . Sialyl Lewis a and sialyl Lewis x were detected with antibodies from clones C0514 and 88H7 (see above), respectively, after Vibrio cholerae neuraminidase treatment (see below). The hybridoma clone producing monoclonal anti-melanoma antibody (Dippold et al., 1980) specific for ganglioside G D3 was obtained from the ATCC (HB 8445).
Cholera toxin B subunit (=choleragenoid) specific for ganglioside G M1 was from Sigma (no. C-7771) and goat anti-choleragenoid antiserum from Calbiochem (Frankfurt a.M., Germany; no. 227040).
TLC immunostaining
Secondary rabbit anti-chicken IgG, goat anti-rat IgG, goat anti-mouse IgG and IgM, and goat anti-rabbit IgG antisera, all affinity chromatography-purified and labeled with alkaline phosphatase, were purchased from Dianova and used in a 1:2000 dilution (Duvar et al., 1997) . Two reviews concerning the details of the TLC immunostaining procedure have been recently published (Müthing, 1996 (Müthing, , 1998 . Anti-Lewis a , anti-Lewis x , anti-sialyl Lewis x , and anti-VIM-2 antigen (CDw65) antibodies were used in a "microscale method" (Müthing et al., 1996a) by applying 80 µl aliquots per cut lane of chromatographed GSLs. Neuraminidase treatment of neolacto-series gangliosides with α2-3 substituted sialic acid is necessary prior to immunostaining with anti-nLcOse 4 Cer antibody, whereas α2-6 sialylated neolacto-type gangliosides can be detected without enzyme treatment, since sialylation at position 6 of the terminal galactose does not hinder recognition (Müthing and Neumann, 1993) . Silica gel fixed plates were incubated with 2.5 mU/ml V.cholerae neuraminidase (Behring Werke AG) for 2 h at room temperature, followed by immunostaining with anti-nLcOse 4 Cer antibody (for details, see Müthing and Neumann, 1993; Müthing et al., 1994a) .
The TLC binding assay using choleragenoid for specific detection of G M1 was developed by Magnani et al. (1980) and was used according to the modifications described by Müthing et al. (1992) .
Mass spectrometric analyses of GSLs
The permethylation was carried out according to Ciucanu and Kerek (1984) . Native GSLs and the derivatives were structurally characterized by negative and positive ion mode fast atom bombardment-mass spectrometry (FAB-MS), respectively, as previously reported (Peter-Katalinic and Egge, 1990) .
Fatty acid analysis
For fatty acid analysis, GSLs were hydrolyzed according to Gaver and Sweeley (1965) with 200 µl of aqueous and methanolic HCl (1 M HCl, 10 M H 2 O) at 100_C for 16 h. The resultant fatty acid methyl esters were extracted three times with 500 µl n-hexane, analyzed by capillary GC-MS, and identified as their molecular and characteristic fragments using the instrumentation described previously (Lochnit et al., 1997) . For the separation of fatty acid species a fused-silica capillary column (DB-1701, 0.25 mm ID, 30 m; ICT, Bad Homburg, Germany) was used. The column temperature was increased at 7_C/min from 80_C to a final temperature of 320_C and held isothermally for 10 min. Spectra were recorded after electron-impact ionization at an electron energy of 1.1215 × 10 -17 J.
Methylation analysis
The GSLs were methylated according to Ciucanu and Kerek (1984) and subjected to sequential hydrolysis, reduction with NaBD 4 and O-acetylation as described by Levery and Hakomori (1987) . The samples were taken up in 20 µl of chloroform and aliquots were injected onto a 15 m DB5 capillary column which was heated from 100 to 300_C in a temperature gradient of 10_C/min. The eluted partially methylated alditol acetates were detected by 70 eV EIMS in an MD800 (interface: 250_C; ion source: 200_C) using the scan modus or single ion monitoring at m/z 118, 159, 175, 189, 190, 205, 231, 233, 234, 261, 275, 290, 305, 318, and 346 .
Immunohistochemistry
HUVECs were seeded with 2 × 10 4 cells/cm 2 in fibronectincoated (Sigma, 10 µg/ml in PBS) 8 well polystyrene Chamber Slides (Nunc GmbH, Wiesbaden-Biebrich, Germany; no. 177445), cultivated until subconfluence, and immunostained as described for bovine aortic endothelial cells (Duvar et al., 1997) .
